7 Einträge gefunden

1. Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrow

   1. Engel, Nils W
   2. Reinert, Jochim
   3. Borchert, Nora M
   4. Panagiota, Victoria
   5. Gabdoulline, Razif
   6. Thol, Felicitas
   7. Heuser, Michael

   2021 - Forschungsinformationssystem des UKE
2. Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

   1. Heuser, Michael
   2. Smith, B Douglas
   3. Fiedler, Walter
   4. Sekeres, Mikkael A
   5. Montesinos, Pau
   6. Leber, Brian
   7. Merchant, Akil

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

   1. Heuser, Michael
   2. Smith, B Douglas
   3. Fiedler, Walter
   4. Sekeres, Mikkael A
   5. Montesinos, Pau
   6. Leber, Brian
   7. Merchant, Akil

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results

   1. Heuser, Michael
   2. Palmisiano, Neil
   3. Mantzaris, Ioannis
   4. Mims, Alice
   5. DiNardo, Courtney
   6. Silverman, Lewis R
   7. Wang, Eunice S

   2020 - Forschungsinformationssystem des UKE
5. The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia

   1. Velthaus, Arne
   2. Cornils, Kerstin
   3. Hennigs, Jan K
   4. Grüb, Saskia
   5. Stamm, Hauke
   6. Wicklein, Daniel
   7. Bokemeyer, Carsten

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
6. Integrative prognostic risk score in acute myeloid leukemia with normal karyotype.

   1. Damm, Frederik
   2. Heuser, Michael
   3. Morgan, Michael
   4. Wagner, Katharina
   5. Görlich, Kerstin
   6. Grosshennig, Anika
   7. Hamwi, Iyas

   2011 - Forschungsinformationssystem des UKE
7. An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemia.

   1. Fiedler, Walter
   2. Mesters, Rolf
   3. Heuser, Michael
   4. Ehninger, Gerhard
   5. Berdel, Wolfgang E
   6. Zirrgiebel, Ute
   7. Robertson, Jane D

   2009 - Forschungsinformationssystem des UKE